USANA Health Sciences, Inc.

Total Valuation

USANA Health Sciences, Inc. carries a market capitalization of 266.42M, placing it among publicly traded companies globally. Its enterprise value stands at 394.06M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

USANA Health Sciences, Inc. currently has 18.46M shares outstanding.

Valuation Ratios

USANA Health Sciences, Inc. trades at a trailing price-to-earnings ratio of 103.28.

Enterprise Valuation

On an enterprise value basis, USANA Health Sciences, Inc. trades at an EV/EBITDA multiple of 6.36 and an EV/FCF ratio of 30.26. The EV/Sales ratio of 0.57 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.18 provides insight into valuation relative to core operating earnings.

Financial Position

USANA Health Sciences, Inc. maintains a current ratio of 6.98, meaning it holds 7.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.71, indicating elevated leverage, while an interest coverage ratio of 150.46 demonstrates strong ability to service its debt obligations.

Financial Efficiency

USANA Health Sciences, Inc. posts a return on equity of -0.50 and a return on invested capital of -0.67.

Taxes

Over the trailing twelve months, USANA Health Sciences, Inc. has paid 22.73M in income taxes, reflecting an effective tax rate of 106.06.

Stock Price Statistics

USANA Health Sciences, Inc.'s stock has declined approximately -54.57979% over the past 52 weeks. The 50-day moving average sits at 18.49, while the 200-day moving average is 19.16.

Income Statement

Over the trailing twelve months, USANA Health Sciences, Inc. generated 690.09M in revenue and converted that into -1.34M in net income, yielding earnings per share of -0.07. EBITDA reached 61.99M, while operating income came in at 32.35M.

Cash Flow

USANA Health Sciences, Inc. produced 4.41M in operating cash flow over the past twelve months. After subtracting -8.64M in capital expenditures, free cash flow totaled -4.23M - equivalent to -0.23 per share.

Margins

USANA Health Sciences, Inc. operates with a gross margin of 77.15, reflecting its pricing power and cost economics. The operating margin of 4.69 and net profit margin of -0.19 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

USANA Health Sciences, Inc.'s most recent stock split took place on November 23, 2016 with a 1:2 split ratio.

Scores

USANA Health Sciences, Inc. posts an Altman Z-Score of 17.30, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.